Previously Recorded
COVID + Life Sciences Industry: Impact and Response
Event summary
2020 has been an unprecedented year, to say the least. COVID impacted our daily lives, physical surroundings and sparked a global conversation. Specifically to the life sciences industry, companies' objectives shifted, deals pivoted and the industry reacted.
Join renowned industry leaders as we explore how COVID impacted the life sciences industry, how companies quickly and swiftly responded and what this could mean for the industry moving forward.
Speakers
- Kate Hillier – Partner, Cooley
- Nicola Maguire – Partner, Cooley
- Irene Pleasure – J.D., Ph.D. Senior Vice President, General Counsel, Vir Biotechnology
- Gregory Went – Co-founder and CEO, SynaVir, Inc.
- Emma Wheatley – Head of Business Development and Deputy General Counsel, CEPI
This webinar is part of our Life Sciences & Healthcare Innovation Program, Cooley’s 14th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Amanda Richardson.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.